349 related articles for article (PubMed ID: 35354729)
1. [COVID-19-associated Guillain-Barré syndrome in infectious period: a case report].
Nishida K; Sakashita K; Uchibori A; Chiba A; Futamura N
Rinsho Shinkeigaku; 2022 Apr; 62(4):293-297. PubMed ID: 35354729
[TBL] [Abstract][Full Text] [Related]
2. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
[TBL] [Abstract][Full Text] [Related]
3. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.
Kang M; Seok HY
J Korean Med Sci; 2022 May; 37(20):e160. PubMed ID: 35607739
[TBL] [Abstract][Full Text] [Related]
4. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
Front Immunol; 2022; 13():894872. PubMed ID: 35924236
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series.
Ryoo N; Son H; Kim JH; Bae DW; An JY
J Korean Med Sci; 2024 Feb; 39(5):e48. PubMed ID: 38317448
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019.
Yakoby J; Litvak I; Yu E
J Emerg Med; 2021 Oct; 61(4):e67-e70. PubMed ID: 34103203
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports.
Zuberbühler P; Conti ME; León-Cejas L; Maximiliano-González F; Bonardo P; Miquelini A; Halfon J; Martínez J; Gutiérrez MV; Reisin R
Rev Neurol; 2021 Mar; 72(6):203-212. PubMed ID: 33710610
[TBL] [Abstract][Full Text] [Related]
10. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
Sii HL; Ng SH; Wong VF; Law WC
Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
[TBL] [Abstract][Full Text] [Related]
11. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
Chakraborty U; Hati A; Chandra A
Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
[TBL] [Abstract][Full Text] [Related]
12. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of 'long COVID-19 syndrome'?
Raahimi MM; Kane A; Moore CE; Alareed AW
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462068
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome as only manifestation of COVID-19 infection.
d'Orsi G; Sica S; Maiorano A; Melchionda D; Lalla A; Montemurro L; Sabetta A; Goffredo R; Lecce B; Fiore JR; Santantonio T; Avolio C
Clin Neurol Neurosurg; 2021 Aug; 207():106775. PubMed ID: 34175645
[TBL] [Abstract][Full Text] [Related]
14. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
[TBL] [Abstract][Full Text] [Related]
15. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation.
Biassoni E; Assini A; Gandoglia I; Benedetti L; Boni S; Pontali E; Feasi M; Gandolfo F; Del Sette M
J Neurovirol; 2021 Aug; 27(4):662-665. PubMed ID: 34341959
[TBL] [Abstract][Full Text] [Related]
16. Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman.
Al-Zadjali MM; Al Shibli E; Al Maskari M; Gujjar AR; Al Asmi A
Sultan Qaboos Univ Med J; 2022 Aug; 22(3):409-412. PubMed ID: 36072070
[TBL] [Abstract][Full Text] [Related]
17. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y
Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924
[TBL] [Abstract][Full Text] [Related]
18. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
Agha Abbaslou M; Karbasi M; Mozhdehipanah H
Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome associated with COVID-19 disease.
Korem S; Gandhi H; Dayag DB
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32958554
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?
Guilmot A; Maldonado Slootjes S; Bissay V; Dubuisson N; de Broglie C; Gille M
Acta Neurol Belg; 2022 Jun; 122(3):703-707. PubMed ID: 34476752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
